Bratton Capital Inc.'s Net Worth

Estimate Recalculated Nov 7, 2024 04:43PM EST

Who is Bratton Capital Inc.

Bratton Capital Inc. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Denali Therapeutics Inc., and Aquestive Therapeutics, Inc..

SEC CIK

Bratton Capital Inc.'s CIK is 0001723783

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Denali Therapeutics Inc.

Investor

Updated Dec 23, 2020

View Quote Details


Form 4	-100.00%	-383.41K	—	—	Dec 23, 2020	12.20M	Disposition	—	Dec 21
Form 4	-14.42%	-64.62K	$80.14	-$5.18M	Dec 15, 2020	12.59M	Sale	—	Dec 11 - Dec 14
Form 4	-35.81%	-250.00K	$23.97	-$5.99M	Jun 30, 2020	14.09M	Sale	—	Jun 26 - Jun 30
Form 4	-26.76%	-255.00K	$24.72	-$6.30M	Jun 23, 2020	14.34M	Sale	—	Jun 19 - Jun 23
Form 4	-14.28%	-158.76K	—	—	Apr 09, 2019	20.42M	Disposition	—	Mar 25
Form 4	1.35%	275.00K	$18.00	—	Dec 14, 2017	20.57M	Purchase	—	Dec 12
Form 3	—	—	—	—	Dec 07, 2017	312.50K	—	—	—

Showing 7 results

Aquestive Therapeutics, Inc.

Investor

Updated Mar 16, 2021

View Quote Details


Form 4	-15.16%	-1.75M	—	—	Mar 16, 2021	9.82M	Disposition	—	Mar 09 - Mar 12
Form 4	—	165.00K	$15.00	$2.48M	Jul 26, 2018	11.58M	Purchase	—	Jul 24

Showing 2 results